Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131


Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.

Schoenfelder EN, Faraone SV, Kollins SH.

Pediatrics. 2014 Jun;133(6):1070-80. doi: 10.1542/peds.2014-0179. Epub 2014 May 12.


Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.

Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, Biederman J.

Arch Pediatr Adolesc Med. 2008 Oct;162(10):916-21. doi: 10.1001/archpedi.162.10.916.


Can we prevent smoking in children with ADHD: a review of the literature.

Modesto-Lowe V, Danforth JS, Neering C, Easton C.

Conn Med. 2010 Apr;74(4):229-36. Review.


A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

Faraone SV, Glatt SJ.

J Clin Psychiatry. 2010 Jun;71(6):754-63. doi: 10.4088/JCP.08m04902pur. Epub 2009 Dec 29.


Adult attention-deficit/hyperactivity disorder and nicotine use: a qualitative study of patient perceptions.

Liebrenz M, Frei A, Fisher CE, Gamma A, Buadze A, Eich D.

BMC Psychiatry. 2014 May 16;14:141. doi: 10.1186/1471-244X-14-141.


Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

Molina BS, Hinshaw SP, Eugene Arnold L, Swanson JM, Pelham WE, Hechtman L, Hoza B, Epstein JN, Wigal T, Abikoff HB, Greenhill LL, Jensen PS, Wells KC, Vitiello B, Gibbons RD, Howard A, Houck PR, Hur K, Lu B, Marcus S; MTA Cooperative Group.

J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):250-63. doi: 10.1016/j.jaac.2012.12.014. Epub 2013 Feb 8.


A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.


Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.


ADHD, stimulant treatment, and growth: a longitudinal study.

Harstad EB, Weaver AL, Katusic SK, Colligan RC, Kumar S, Chan E, Voigt RG, Barbaresi WJ.

Pediatrics. 2014 Oct;134(4):e935-44. doi: 10.1542/peds.2014-0428. Epub 2014 Sep 1.


Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder.

Coughlin CG, Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Bloch MH.

J Child Adolesc Psychopharmacol. 2015 Oct;25(8):611-7. doi: 10.1089/cap.2015.0075. Epub 2015 Sep 24.


The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood.

Harty SC, Ivanov I, Newcorn JH, Halperin JM.

J Child Adolesc Psychopharmacol. 2011 Aug;21(4):331-9. doi: 10.1089/cap.2010.0074. Epub 2011 Aug 8.


Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.

McCabe SE, Dickinson K, West BT, Wilens TE.

J Am Acad Child Adolesc Psychiatry. 2016 Jun;55(6):479-86. doi: 10.1016/j.jaac.2016.03.011. Epub 2016 Apr 7.


Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder.

Groenman AP, Oosterlaan J, Rommelse NN, Franke B, Greven CU, Hoekstra PJ, Hartman CA, Luman M, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV.

Br J Psychiatry. 2013 Aug;203(2):112-9. doi: 10.1192/bjp.bp.112.124784. Epub 2013 Jul 11. Erratum in: Br J Psychiatry. 2014 Jun;204(6):494.


Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate.

Hammerness P, Joshi G, Doyle R, Georgiopoulos A, Geller D, Spencer T, Petty CR, Faraone SV, Biederman J.

J Pediatr. 2013 Jan;162(1):22-7.e2. doi: 10.1016/j.jpeds.2012.06.046. Epub 2012 Aug 9.


Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?

Rohatgi RK, Bos JM, Ackerman MJ.

Heart Rhythm. 2015 Aug;12(8):1807-12. doi: 10.1016/j.hrthm.2015.04.043. Epub 2015 May 5.

Supplemental Content

Support Center